Emotion Awareness and Skills Enhancement Program

NCT ID: NCT03432832

Last Updated: 2025-04-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

113 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-30

Study Completion Date

2024-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project will address impaired emotion regulation in adolescents with ASD (autism spectrum disorder). There are no evidence-based interventions to improve emotion regulation (ER) in this population, yet poor emotion regulation often leads to maladaptive behavior and substantially impedes capacity to learn and function across all life settings, and reduce their quality of life and that of their families. The primary objective of this study is to formally evaluate efficacy of EASE via a sufficiently powered, two-site randomized-controlled trial (RCT).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The current study is to test a new intervention called Emotional Awareness and Skills Enhancement (EASE). This program was designed to address ASD-specific obstacles to effective emotion regulation, such as reduced awareness concerning others' intentions, a limited repertoire of behavioral responses, and inadequate language for understanding emotional experiences. This new program is based on an acceptance-based approach in which awareness of emotion is developed, emotions (whether negative or positive) are accepted, and behavior is regulated in the face of intense emotion. The goal is not to learn to avoid negative emotions, but rather to develop a collection of abilities which allow the individual to manage stress and act in ways that are more adaptive. The investigators expect to find that participants' emotion dysregulation will decrease and their adaptive function will increase following completion of the EASE program.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

per protocol analysis versus intent to treat analytic approach due to the pandemic
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Emotion Awareness/Skills Enhancement

EASE Therapy includes 16 weekly sessions focused on mindfulness exercise, review of prior content, practicing prior skills, outline of current session, discussion of the new skill, handouts, practice and plan for out of session practice held in Webster Hall in Pittsburgh, at the Center for the Prevention of Youth Behavior Problems in Tuscaloosa or via telehealth conferencing software. The investigators will apply a multimodal teaching approach, where individual therapy is buttressed by parent involvement and practice sessions in the youth's community. A secure website developed for this project (emotion-Coach or "e-Coach") will augment the intervention by providing online supports to increase treatment intensity or dosage. There will be specific information on how to reinforce the skills at home and in the community.

Group Type EXPERIMENTAL

EASE

Intervention Type BEHAVIORAL

Weekly behavioral sessions with therapist to work on emotional control through measures such as mindfulness.

Supportive Therapy

Supportive Therapy will involve attending 16 weekly therapy sessions held in Webster Hall in Pittsburgh, at the Center for the Prevention of Youth Behavior Problems in Tuscaloosa or via telehealth conferencing software. The intervention will not involve mindfulness or other emotion regulation strategies used in EASE. The therapy will be tailored to the individual's needs and will include aspects common in supportive therapy such as reflective listening, antecedent management, and problem-solving. This program does not have an online component.

Group Type ACTIVE_COMPARATOR

Supportive Therapy

Intervention Type BEHAVIORAL

Weekly behavioral sessions with a therapist to work on emotional control

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EASE

Weekly behavioral sessions with therapist to work on emotional control through measures such as mindfulness.

Intervention Type BEHAVIORAL

Supportive Therapy

Weekly behavioral sessions with a therapist to work on emotional control

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. ages 12-21 years, inclusive
2. A diagnosis of ASD (autism spectrum disorder), as defined by exceeding the ASD cutoff on the ADOS-2 (Autism Diagnostic Observation Scale) or ADI-R (Autism Diagnostic Interview-Revised) In. If the participant has completed the ADOS in a previous study within 3 years and signs a release of information to obtain it, they will not be required to complete another ADOS.
3. Average verbal intellectual ability (Wechsler Abbreviated Scale of Intelligence-2 \[WASI-2\] FSIQ \>=75).
4. Fluent in the English language
5. Problems with regulating emotions based on parent report 6) Parent/guardian who will attend sessions and assessments.

Exclusion Criteria

1. Current concerns of suicidality that warrants immediate clinical care (such potential participants will be referred elsewhere for treatment), determined by clinical interview.
2. Previous or current diagnosis of a psychotic disorder.
3. Receiving concurrent psychotherapy treatment for emotional issues (i.e., depression, anxiety, anger) that overlaps with the current study. This will be assessed using current treatment items on the demographic forms.
Minimum Eligible Age

12 Years

Maximum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Alabama at Birmingham

OTHER

Sponsor Role collaborator

University of Pittsburgh

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Carla Mazefsky

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carla Mazefsky, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Pittsburgh

Susan White

Role: PRINCIPAL_INVESTIGATOR

University of Alabama at Birmingham

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama

Tuscaloosa, Alabama, United States

Site Status

Shannondora Porton

Pittsburgh, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Abidin, R. R. (2012). Parenting Stress Index, Fourth Edition Short Form (PSI-4). Lutz, FL: PAR.

Reference Type BACKGROUND

Achenbach, T. M., & Rescorla, L. (2001). Manual for the ASEBA school-age forms and profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, & Families.

Reference Type BACKGROUND

Aldao A, Nolen-Hoeksema S, Schweizer S. Emotion-regulation strategies across psychopathology: A meta-analytic review. Clin Psychol Rev. 2010 Mar;30(2):217-37. doi: 10.1016/j.cpr.2009.11.004. Epub 2009 Nov 20.

Reference Type BACKGROUND
PMID: 20015584 (View on PubMed)

Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985 Mar;89(5):485-91.

Reference Type BACKGROUND
PMID: 3993694 (View on PubMed)

Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. J Child Adolesc Psychopharmacol. 2015 Aug;25(6):482-93. doi: 10.1089/cap.2015.0005.

Reference Type BACKGROUND
PMID: 26262903 (View on PubMed)

Anagnostou E, Jones N, Huerta M, Halladay AK, Wang P, Scahill L, Horrigan JP, Kasari C, Lord C, Choi D, Sullivan K, Dawson G. Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder. Autism. 2015 Jul;19(5):622-36. doi: 10.1177/1362361314542955. Epub 2014 Aug 5.

Reference Type BACKGROUND
PMID: 25096930 (View on PubMed)

Anderson DK, Liang JW, Lord C. Predicting young adult outcome among more and less cognitively able individuals with autism spectrum disorders. J Child Psychol Psychiatry. 2014 May;55(5):485-94. doi: 10.1111/jcpp.12178. Epub 2013 Dec 9.

Reference Type BACKGROUND
PMID: 24313878 (View on PubMed)

Arnett JJ. Emerging adulthood. A theory of development from the late teens through the twenties. Am Psychol. 2000 May;55(5):469-80.

Reference Type BACKGROUND
PMID: 10842426 (View on PubMed)

Baker AE, Lane A, Angley MT, Young RL. The relationship between sensory processing patterns and behavioural responsiveness in autistic disorder: a pilot study. J Autism Dev Disord. 2008 May;38(5):867-75. doi: 10.1007/s10803-007-0459-0.

Reference Type BACKGROUND
PMID: 17899349 (View on PubMed)

Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986 Dec;51(6):1173-82. doi: 10.1037//0022-3514.51.6.1173.

Reference Type BACKGROUND
PMID: 3806354 (View on PubMed)

Baskin TW, Tierney SC, Minami T, Wampold BE. Establishing specificity in psychotherapy: a meta-analysis of structural equivalence of placebo controls. J Consult Clin Psychol. 2003 Dec;71(6):973-9. doi: 10.1037/0022-006X.71.6.973.

Reference Type BACKGROUND
PMID: 14622072 (View on PubMed)

Bishop-Fitzpatrick L, Minshew NJ, Eack SM. A systematic review of psychosocial interventions for adults with autism spectrum disorders. J Autism Dev Disord. 2013 Mar;43(3):687-94. doi: 10.1007/s10803-012-1615-8.

Reference Type BACKGROUND
PMID: 22825929 (View on PubMed)

Boulter C, Freeston M, South M, Rodgers J. Intolerance of uncertainty as a framework for understanding anxiety in children and adolescents with autism spectrum disorders. J Autism Dev Disord. 2014 Jun;44(6):1391-402. doi: 10.1007/s10803-013-2001-x.

Reference Type BACKGROUND
PMID: 24272526 (View on PubMed)

Carroll D, Hallett V, McDougle CJ, Aman MG, McCracken JT, Tierney E, Arnold LE, Sukhodolsky DG, Lecavalier L, Handen BL, Swiezy N, Johnson C, Bearss K, Vitiello B, Scahill L. Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems. Child Adolesc Psychiatr Clin N Am. 2014 Jan;23(1):57-72. doi: 10.1016/j.chc.2013.08.002.

Reference Type BACKGROUND
PMID: 24231167 (View on PubMed)

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012 Mar 30;61(3):1-19.

Reference Type BACKGROUND
PMID: 22456193 (View on PubMed)

Chiesa A, Serretti A, Jakobsen JC. Mindfulness: top-down or bottom-up emotion regulation strategy? Clin Psychol Rev. 2013 Feb;33(1):82-96. doi: 10.1016/j.cpr.2012.10.006. Epub 2012 Oct 23.

Reference Type BACKGROUND
PMID: 23142788 (View on PubMed)

Connor-Smith JK, Compas BE, Wadsworth ME, Thomsen AH, Saltzman H. Responses to stress in adolescence: measurement of coping and involuntary stress responses. J Consult Clin Psychol. 2000 Dec;68(6):976-92.

Reference Type BACKGROUND
PMID: 11142550 (View on PubMed)

Constantino JN, Abbacchi AM, Lavesser PD, Reed H, Givens L, Chiang L, Gray T, Gross M, Zhang Y, Todd RD. Developmental course of autistic social impairment in males. Dev Psychopathol. 2009 Winter;21(1):127-38. doi: 10.1017/S095457940900008X.

Reference Type BACKGROUND
PMID: 19144226 (View on PubMed)

Croen LA, Najjar DV, Ray GT, Lotspeich L, Bernal P. A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics. 2006 Oct;118(4):e1203-11. doi: 10.1542/peds.2006-0127.

Reference Type BACKGROUND
PMID: 17015508 (View on PubMed)

Croen LA, Zerbo O, Qian Y, Massolo ML, Rich S, Sidney S, Kripke C. The health status of adults on the autism spectrum. Autism. 2015 Oct;19(7):814-23. doi: 10.1177/1362361315577517. Epub 2015 Apr 24.

Reference Type BACKGROUND
PMID: 25911091 (View on PubMed)

Crone EA, Dahl RE. Understanding adolescence as a period of social-affective engagement and goal flexibility. Nat Rev Neurosci. 2012 Sep;13(9):636-50. doi: 10.1038/nrn3313.

Reference Type BACKGROUND
PMID: 22903221 (View on PubMed)

Davidson RJ, Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D, Santorelli SF, Urbanowski F, Harrington A, Bonus K, Sheridan JF. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med. 2003 Jul-Aug;65(4):564-70. doi: 10.1097/01.psy.0000077505.67574.e3.

Reference Type BACKGROUND
PMID: 12883106 (View on PubMed)

Denissen JJ, Penke L, Schmitt DP, van Aken MA. Self-esteem reactions to social interactions: evidence for sociometer mechanisms across days, people, and nations. J Pers Soc Psychol. 2008 Jul;95(1):181-96. doi: 10.1037/0022-3514.95.1.181.

Reference Type BACKGROUND
PMID: 18605859 (View on PubMed)

Eack SM, Greenwald DP, Hogarty SS, Bahorik AL, Litschge MY, Mazefsky CA, Minshew NJ. Cognitive enhancement therapy for adults with autism spectrum disorder: results of an 18-month feasibility study. J Autism Dev Disord. 2013 Dec;43(12):2866-77. doi: 10.1007/s10803-013-1834-7.

Reference Type BACKGROUND
PMID: 23619953 (View on PubMed)

Eaves LC, Ho HH. Young adult outcome of autism spectrum disorders. J Autism Dev Disord. 2008 Apr;38(4):739-47. doi: 10.1007/s10803-007-0441-x. Epub 2007 Sep 1.

Reference Type BACKGROUND
PMID: 17764027 (View on PubMed)

Gamez W, Chmielewski M, Kotov R, Ruggero C, Suzuki N, Watson D. The brief experiential avoidance questionnaire: development and initial validation. Psychol Assess. 2014 Mar;26(1):35-45. doi: 10.1037/a0034473. Epub 2013 Sep 23.

Reference Type BACKGROUND
PMID: 24059474 (View on PubMed)

Gerdts J, Bernier R. The broader autism phenotype and its implications on the etiology and treatment of autism spectrum disorders. Autism Res Treat. 2011;2011:545901. doi: 10.1155/2011/545901. Epub 2011 Aug 17.

Reference Type BACKGROUND
PMID: 22937250 (View on PubMed)

Gotham K, Brunwasser SM, Lord C. Depressive and anxiety symptom trajectories from school age through young adulthood in samples with autism spectrum disorder and developmental delay. J Am Acad Child Adolesc Psychiatry. 2015 May;54(5):369-76.e3. doi: 10.1016/j.jaac.2015.02.005. Epub 2015 Feb 17.

Reference Type BACKGROUND
PMID: 25901773 (View on PubMed)

Gotink RA, Chu P, Busschbach JJ, Benson H, Fricchione GL, Hunink MG. Standardised mindfulness-based interventions in healthcare: an overview of systematic reviews and meta-analyses of RCTs. PLoS One. 2015 Apr 16;10(4):e0124344. doi: 10.1371/journal.pone.0124344. eCollection 2015.

Reference Type BACKGROUND
PMID: 25881019 (View on PubMed)

Greco LA, Baer RA, Smith GT. Assessing mindfulness in children and adolescents: development and validation of the Child and Adolescent Mindfulness Measure (CAMM). Psychol Assess. 2011 Sep;23(3):606-14. doi: 10.1037/a0022819.

Reference Type BACKGROUND
PMID: 21480722 (View on PubMed)

Gu J, Strauss C, Bond R, Cavanagh K. How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies. Clin Psychol Rev. 2015 Apr;37:1-12. doi: 10.1016/j.cpr.2015.01.006. Epub 2015 Jan 31.

Reference Type BACKGROUND
PMID: 25689576 (View on PubMed)

Guy L, Souders M, Bradstreet L, DeLussey C, Herrington JD. Brief report: emotion regulation and respiratory sinus arrhythmia in autism spectrum disorder. J Autism Dev Disord. 2014 Oct;44(10):2614-20. doi: 10.1007/s10803-014-2124-8.

Reference Type BACKGROUND
PMID: 24752681 (View on PubMed)

Hodges K, Kim CS. Psychometric study of the Child and Adolescent Functional Assessment Scale: prediction of contact with the law and poor school attendance. J Abnorm Child Psychol. 2000 Jun;28(3):287-97. doi: 10.1023/a:1005100521818.

Reference Type BACKGROUND
PMID: 10885686 (View on PubMed)

Howlin P, Goode S, Hutton J, Rutter M. Adult outcome for children with autism. J Child Psychol Psychiatry. 2004 Feb;45(2):212-29. doi: 10.1111/j.1469-7610.2004.00215.x.

Reference Type BACKGROUND
PMID: 14982237 (View on PubMed)

Ives-Deliperi VL, Solms M, Meintjes EM. The neural substrates of mindfulness: an fMRI investigation. Soc Neurosci. 2011;6(3):231-42. doi: 10.1080/17470919.2010.513495. Epub 2010 Sep 9.

Reference Type BACKGROUND
PMID: 20835972 (View on PubMed)

Khor AS, Melvin GA, Reid SC, Gray KM. Coping, daily hassles and behavior and emotional problems in adolescents with high-functioning autism/Asperger's Disorder. J Autism Dev Disord. 2014 Mar;44(3):593-608. doi: 10.1007/s10803-013-1912-x.

Reference Type BACKGROUND
PMID: 23933998 (View on PubMed)

MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002 Mar;7(1):83-104. doi: 10.1037/1082-989x.7.1.83.

Reference Type BACKGROUND
PMID: 11928892 (View on PubMed)

Mazefsky CA, Minshew NJ. The spectrum of autism-from neuronal connections to behavioral expression. Virtual Mentor. 2010 Nov 1;12(11):867-72. doi: 10.1001/virtualmentor.2010.12.11.cprl1-1011.

Reference Type BACKGROUND
PMID: 23186793 (View on PubMed)

Mazefsky CA, Conner CM, Oswald DP. Association between depression and anxiety in high-functioning children with autism spectrum disorders and maternal mood symptoms. Autism Res. 2010 Jun;3(3):120-7. doi: 10.1002/aur.133.

Reference Type BACKGROUND
PMID: 20578069 (View on PubMed)

Mazefsky CA, Borue X, Day TN, Minshew NJ. Emotion regulation patterns in adolescents with high-functioning autism spectrum disorder: comparison to typically developing adolescents and association with psychiatric symptoms. Autism Res. 2014 Jun;7(3):344-54. doi: 10.1002/aur.1366. Epub 2014 Mar 7.

Reference Type BACKGROUND
PMID: 24610869 (View on PubMed)

Mazefsky CA, Day TN, Siegel M, White SW, Yu L, Pilkonis PA; Autism and Developmental Disabilities Inpatient Research Collaborative (ADDIRC). Development of the Emotion Dysregulation Inventory: A PROMIS(R)ing Method for Creating Sensitive and Unbiased Questionnaires for Autism Spectrum Disorder. J Autism Dev Disord. 2018 Nov;48(11):3736-3746. doi: 10.1007/s10803-016-2907-1.

Reference Type BACKGROUND
PMID: 27699685 (View on PubMed)

Mazefsky CA, White SW. Emotion regulation: concepts & practice in autism spectrum disorder. Child Adolesc Psychiatr Clin N Am. 2014 Jan;23(1):15-24. doi: 10.1016/j.chc.2013.07.002. Epub 2013 Aug 30.

Reference Type BACKGROUND
PMID: 24231164 (View on PubMed)

McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D; Research Units on Pediatric Psychopharmacology Autism Network. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002 Aug 1;347(5):314-21. doi: 10.1056/NEJMoa013171.

Reference Type BACKGROUND
PMID: 12151468 (View on PubMed)

Piacentini J, Woods DW, Scahill L, Wilhelm S, Peterson AL, Chang S, Ginsburg GS, Deckersbach T, Dziura J, Levi-Pearl S, Walkup JT. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010 May 19;303(19):1929-37. doi: 10.1001/jama.2010.607.

Reference Type BACKGROUND
PMID: 20483969 (View on PubMed)

Rieffe C, De Bruine M, De Rooij M, Stockmann L. Approach and avoidant emotion regulation prevent depressive symptoms in children with an Autism Spectrum Disorder. Int J Dev Neurosci. 2014 Dec;39:37-43. doi: 10.1016/j.ijdevneu.2014.06.003. Epub 2014 Jun 19.

Reference Type BACKGROUND
PMID: 24951836 (View on PubMed)

Shallcross AJ, Gross JJ, Visvanathan PD, Kumar N, Palfrey A, Ford BQ, Dimidjian S, Shirk S, Holm-Denoma J, Goode KM, Cox E, Chaplin W, Mauss IB. Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition. J Consult Clin Psychol. 2015 Oct;83(5):964-75. doi: 10.1037/ccp0000050. Epub 2015 Aug 10.

Reference Type BACKGROUND
PMID: 26371618 (View on PubMed)

Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 2008 Aug;47(8):921-9. doi: 10.1097/CHI.0b013e318179964f.

Reference Type BACKGROUND
PMID: 18645422 (View on PubMed)

Taylor JL, Mailick MR. A longitudinal examination of 10-year change in vocational and educational activities for adults with autism spectrum disorders. Dev Psychol. 2014 Mar;50(3):699-708. doi: 10.1037/a0034297. Epub 2013 Sep 2.

Reference Type BACKGROUND
PMID: 24001150 (View on PubMed)

Verheij C, Louwerse A, van der Ende J, Eussen ML, Van Gool AR, Verheij F, Verhulst FC, Greaves-Lord K. The Stability of Comorbid Psychiatric Disorders: A 7 Year Follow Up of Children with Pervasive Developmental Disorder-Not Otherwise Specified. J Autism Dev Disord. 2015 Dec;45(12):3939-48. doi: 10.1007/s10803-015-2592-5.

Reference Type BACKGROUND
PMID: 26456972 (View on PubMed)

White SW, Albano AM, Johnson CR, Kasari C, Ollendick T, Klin A, Oswald D, Scahill L. Development of a cognitive-behavioral intervention program to treat anxiety and social deficits in teens with high-functioning autism. Clin Child Fam Psychol Rev. 2010 Mar;13(1):77-90. doi: 10.1007/s10567-009-0062-3.

Reference Type BACKGROUND
PMID: 20091348 (View on PubMed)

White SW, Ollendick T, Albano AM, Oswald D, Johnson C, Southam-Gerow MA, Kim I, Scahill L. Randomized controlled trial: Multimodal Anxiety and Social Skill Intervention for adolescents with autism spectrum disorder. J Autism Dev Disord. 2013 Feb;43(2):382-94. doi: 10.1007/s10803-012-1577-x.

Reference Type BACKGROUND
PMID: 22735897 (View on PubMed)

White SW, Elias R, Salinas CE, Capriola N, Conner CM, Asselin SB, Miyazaki Y, Mazefsky CA, Howlin P, Getzel EE. Students with autism spectrum disorder in college: Results from a preliminary mixed methods needs analysis. Res Dev Disabil. 2016 Sep;56:29-40. doi: 10.1016/j.ridd.2016.05.010. Epub 2016 Jun 1.

Reference Type BACKGROUND
PMID: 27262124 (View on PubMed)

White SW, Elias R, Capriola-Hall NN, Smith IC, Conner CM, Asselin SB, Howlin P, Getzel EE, Mazefsky CA. Development of a College Transition and Support Program for Students with Autism Spectrum Disorder. J Autism Dev Disord. 2017 Oct;47(10):3072-3078. doi: 10.1007/s10803-017-3236-8.

Reference Type BACKGROUND
PMID: 28685409 (View on PubMed)

White SW, Conner CM, Beck K, Mazefsky CA. Efficacy of the Emotion Awareness and Skills Enhancement (EASE) Program in Autism: A Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry. 2025 Jul 31:S0890-8567(25)01410-8. doi: 10.1016/j.jaac.2025.07.1058. Online ahead of print.

Reference Type DERIVED
PMID: 40750084 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY20110317

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

STEPS Implementation Trial
NCT05695885 RECRUITING NA